Sage Rhino Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $220K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $242K | Sell |
|
|||||
|
2024
Q2 | $256K | Sell |
|
|||||
|
2024
Q1 | $233K | Buy |
|
|||||
|
2023
Q4 | $225K | Sell |
|
|||||
|
2023
Q3 | $211K | Sell |
|
|||||
|
2023
Q2 | $215K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $263K | Sell |
|
|||||
|
2022
Q1 | $387K | Sell |
|
|||||
|
2021
Q4 | $345K | Buy |
|
|||||
|
2021
Q3 | $280K | Buy |
|
|||||
|
2021
Q2 | $307K | Buy |
|
|||||
|
2021
Q1 | $325K | Buy |
|
|||||
|
2020
Q4 | $295K | Buy |
|
|||||
|
2020
Q3 | $308K | Buy |
|
|||||
|
2020
Q2 | $302K | Buy |
|
|||||
|
2020
Q1 | $241K | Sell |
|
|||||
|
2019
Q4 | $234K | Buy |
|